Author response for 'The efficacy and safety of Epstein‐Barr virus specific antigen peptide‐activated cytotoxic T cells treatment for refractory or recurrent angioimmunoblastic T cell lymphoma: A prospective clinical observational study'

Autor:	null Wang Bingjie, null Wang Lihong, null Shi Yongjin, null Liu Huihui, null Ou Jinping, null Cen Xi'nan
Rok vydání:	2020
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2636488490bf516efedc523c1f0dfd5e https://doi.org/10.1002/hon.2726/v2/response1 Zobrazit plný text záznamu